T3 Companies, LLC

Position in YARW — Yarrow Bioscience, Inc.

CIK 2052441 NEW YORK, NY

Position in YARW

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$615,195

+$50,085 QoQ

Shares Held

945,000

0.0% QoQ

Ownership

2.83%

of shares outstanding

% of Portfolio

0.78%

of 13F equity value

Holder Rank

of 4 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $2,660,789 across 5 Biotechnology names. YARW ranks #3 (23.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	7,815	$1,041,426
2	IFRX	InflaRx N.V.	331,014	$741,471
3	YARW	Yarrow Bioscience, Inc. This page	945,000	$615,195
4	CLDX	Celldex Therapeutics, Inc.	6,000	$223,260
5	SANA	Sana Biotechnology, Inc.	11,300	$39,437

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$615,195	945,000	0.0%	Shares	Sole	2026-07-27
2026-03-31	$565,110	945,000	0.0%	Shares	Sole	2026-05-07
2025-12-31	$548,100	945,000	—	Shares	Sole	2026-02-11
No filing history on record for this holder in this stock.